製品名:ethyl 4-bromo-3-(ethoxymethyl)benzoate

IUPAC Name:ethyl 4-bromo-3-(ethoxymethyl)benzoate

CAS番号:948349-66-4
分子式:C12H15BrO3
純度:95%+
カタログ番号:CM1015264
分子量:287.15

包装単位 有効在庫 価格(USD) 数量
CM1015264-5g in stock ňƩƻ

研究開発用専用.

問い合わせフォーム

   refresh    

製品詳細

CAS番号:948349-66-4
分子式:C12H15BrO3
融点:-
SMILESコード:CCOCC1=C(C=CC(=C1)C(=O)OCC)Br
密度:
カタログ番号:CM1015264
分子量:287.15
沸点:
MDL番号:
保管方法:

Category Infos

Benzenes
Benzene is an important organic compound with the chemical formula C6H6, and its molecule consists of a ring of 6 carbon atoms, each with 1 hydrogen atom. Benzene is a sweet, flammable, colorless and transparent liquid with carcinogenic toxicity at room temperature, and has a strong aromatic odor. It is insoluble in water, easily soluble in organic solvents, and can also be used as an organic solvent itself. The ring system of benzene is called benzene ring, and the structure after removing one hydrogen atom from the benzene ring is called phenyl. Benzene is one of the most important basic organic chemical raw materials. Many important chemical intermediates can be derived from benzene through substitution reaction, addition reaction and benzene ring cleavage reaction.

Column Infos

Sparsentan
CSL Vifor and Travere Therapeutics announce European Commission approves FILSPARI(sparsentan) for the treatment of IgA Nephropathy (IgAN). First non-immunosuppressive therapy for the treatment of IgAN approved in Europe.
Sparsentan is a novel, non-immunosuppressive, single-molecule, dual endothelin angiotensin receptor antagonist with high selectivity for the endothelin A receptor (ETAR) and the angiotensin II subtype 1 receptor (AT1R). Pre-clinical data have shown that blockade of both endothelin type A and angiotensin II type 1 pathways in forms of rare chronic kidney disease, protects podocytes, prevents glomerulosclerosis and mesangial cell proliferation, and reduces proteinuria. 

Related Products